ÂÜÀòÂÒÂ×

Christina Strange currently serves as the Senior Director of Analytical Development at Abata Therapeutics since July 2022. Previous positions include Associate Director of Analytical Development at BioNTech SE, where responsibilities included leading global technology transfer for autologous T cell therapy products, and Senior Research Scientist at Kite Pharma, focused on executing technology transfer and supporting IND filing activities. Earlier in their career, Christina held roles at Canon U.S. Life Sciences as Principal Scientist, where Christina led microbiology efforts for diagnostic devices, and at Life Technologies as Senior Scientist, developing multiplex immunoassays. Experience also includes positions at MedImmune and Digene Corporation, where analytical methods and assays were developed. Christina holds a Master’s degree in Biotechnology from The Johns Hopkins University and a Bachelor’s degree in Biology with a minor in Chemistry from Hood College, as well as a Certificate in Regulatory Compliance from Hood College.